-
Covalently conjugated NOD2/TLR7 agonists are potent and versatile immune potentiators [Elektronski vir]Guzelj, Samo ...The success of vaccination with subunit vaccines often relies on the careful choice of adjuvants. There is great interest in developing new adjuvants that can elicit a cellular immune response. Here, ... we address this challenge by taking advantage of the synergistic cross-talk between two pattern recognition receptors: nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) and Toll-like receptor 7 (TLR7). We designed two conjugated NOD2/TLR7 agonists, which showed potent immunostimulatory activities in human primary peripheral blood mononuclear cells and murine bone-marrow-derived dendritic cells. One of these, 4, also generated a strong antigen-specific immune response in vivo, with a Th1-polarized profile. Importantly, our study shows that novel NOD2/TLR7 agonists elicit sophisticated and fine-tuned immune responses that are inaccessible to individual NOD2 and TLR7 agonists.Source: Journal of medicinal chemistry [Elektronski vir]. - ISSN 1520-4804 (Vol. 65, no. 22, 2022, str. 15085–15101)Type of material - e-article ; adult, seriousPublish date - 2022Language - englishCOBISS.SI-ID - 128189187
Author
Guzelj, Samo |
Weiss, Matjaž |
Slütter, Bram |
Frkanec, Ruža |
Jakopin, Žiga
Topics
Cepiva |
Imunski odziv |
immunostimulatory activity |
vaccines |
immune responses |
pattern recognition receptors |
synthesis of NOD2 agonist |
Toll-like receptor 7 |
imunostimulatorna aktivnost |
imunski odziv |
receptorji za prepoznavanje vzorcev |
sinteza agonista NOD2 |
Tollu podoben receptor 7
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Author | Guzelj, Samo ... |
Title | Covalently conjugated NOD2/TLR7 agonists are potent and versatile immune potentiators [Elektronski vir] |
Publication date | |
COBISS.SI-ID | 128189187 |
Publication version in repository | Publisher's version |
Publication licence | Creative Commons Attribution 4.0 International |
Embargo | Immediate publication for public |
Project(s) from which the publication was funded
Title | Acronym | Project ID | Funder |
---|---|---|---|
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin | P1-0208-2022 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
|
Napredna imunološka zdravila in celični pristopi v farmaciji | P1-0420-2022 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
|
Razvoj agonistov receptorja NOD2 ter dualnih NOD2/TLR7 agonističnih konjugatov kot novih adjuvansov za cepiva | J3-9256-2018 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
Files that belong to the publication
Link |
---|
![]() |
![]() |
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Guzelj, Samo | 52379 |
Weiss, Matjaž | 50503 |
Slütter, Bram | ![]() |
Frkanec, Ruža | ![]() |
Jakopin, Žiga | 26496 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.